Analysts Express Optimism for Axsome Therapeutics with Positive Price Targets
As of November 7, 2023, a group of 5 analysts have provided their 12-month price targets for Axsome Therapeutics, reflecting ...
Tag: AXSM
Cantor Fitzgerald Analyst Reiterates Confidence in Axsome Therapeutics Potential Treatment for Alzheimers Disease Agitation
On November 7, 2023, Cantor Fitzgerald analyst Charles Duncan expressed his continued confidence in Axsome Therapeutics (NASDAQ:AXSM) by reiterating an ...
Axsome Therapeutics Inc Reports Impressive Q3 2023 Financial Results and Focuses on Market Expansion
On November 6, 2023, Axsome Therapeutics Inc. (NASDAQ:AXSM) announced impressive financial results for Q3 2023. The company reported revenues of ...
Ceragon Networks Ltd Raises Revenue Guidance for FY23 and Sets Ambitious Targets
Ceragon Networks Ltd, a renowned global leader in the field of 5G wireless transport, has recently revised its revenue guidance ...
Insider Transactions A Closer Look at Axsome Therapeutics
On October 13, 2023, an exciting development took place at Axsome Therapeutics. Susan Mahony, the esteemed Director of the company, ...
Axsome Therapeutics Receives Positive Ratings and Maintains Moderate Buy Consensus
As of September 25, 2023, Axsome Therapeutics (NASDAQ: AXSM) has received evaluations from 8 analysts who have provided their 12-month ...
Optimistic Outlook for Axsome Therapeutics Analysts Predict Promising Future
As of September 25, 2023, various reputable sources have expressed an optimistic view on Axsome Therapeutics, a pharmaceutical company. These ...
Aristotle Capital Boston LLC Increases Stake in AZZ Inc. as Company Faces Opportunities and Challenges in a Shifting Market
On September 12, 2023, Aristotle Capital Boston LLC announced that it has increased its stake in AZZ Inc. (NYSE:AZZ) by ...
BVF Inc. IL Increases Stake in Axsome Therapeutics: Demonstrates Confidence in CNS Disorder Treatments
BVF Inc. IL, an investment firm, has recently increased its stake in Axsome Therapeutics, Inc. by 21.4% during the first ...
Significant Increase in Holdings: & Fmr LLC Shows Confidence in Axsome Therapeutics’ Potential in CNS Disorders Market
On September 5, 2023, it was reported that & Fmr LLC had significantly increased its holdings in Axsome Therapeutics, Inc. ...